Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Return on Assets (2017 - 2025)

Acro Biomedical (ACBM) has 9 years of Return on Assets data on record, last reported at 10.98% in Q4 2025.

  • For Q4 2025, Return on Assets fell 978.0% year-over-year to 10.98%; the TTM value through Dec 2025 reached 10.98%, down 978.0%, while the annual FY2025 figure was 4.39%, 346.0% down from the prior year.
  • Return on Assets reached 10.98% in Q4 2025 per ACBM's latest filing, down from 5.36% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.27% in Q1 2021 and bottomed at 227.33% in Q4 2023.
  • Average Return on Assets over 5 years is 26.68%, with a median of 9.18% recorded in 2022.
  • Peak YoY movement for Return on Assets: tumbled -20349bps in 2023, then skyrocketed 22614bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 2.33% in 2021, then crashed by -923bps to 23.85% in 2022, then tumbled by -853bps to 227.33% in 2023, then skyrocketed by 99bps to 1.2% in 2024, then tumbled by -817bps to 10.98% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 10.98% in Q4 2025, 5.36% in Q3 2025, and 1.19% in Q2 2025.